Information about miacalcic ampoules effective for the treatment of osteoporosis after menopause in menopause in women, as it is considered the early treatment of cases of hypercalcemia and treats moderate Paget's patients, because it contains the active ingredient calcitonin, which regulates calcium levels in the blood.
Ingredients for miacalcic ampoules
miacalcic ampoules are composed on the active ingredient calcitonin, as they regulate calcium levels in the blood and regulate the excretion of calcium, phosphorus and magnesium in the kidneys.
About miacalcic Ampoules
- Drug Category : Endocrinology
- Drug classification : Thyroid metabolic agent
- Active ingredient : Calcitonin
- Indications : Treatment of osteoporosis after menopause